Suggestions appear as you type. Use the up and down arrows to choose one and Enter to open it.

Us2.ai review

#5 of 54 in Medical Imaging Analytics Software

A cardiac-focused echo analytics platform with automated measurements, conclusions and structured reports.

8.6/10Editor score
Us2.ai8.6 Visit Us2.ai

Reviewed by iTechGuides Editors · Editorial team · Updated Nov 2026

Us2.ai is a software-as-a-medical-device platform for cardiology teams analyzing transthoracic echocardiogram images. It generates automated cardiac measurements, guideline-based conclusions and structured reports for clinician review. The workflow covers chamber quantification, systolic and diastolic function, global and regional longitudinal strain, valvular assessment, heart-failure categories, aortic-stenosis grading and pulmonary-hypertension probability. A separately cleared Us2.ca module identifies studies suggestive of cardiac amyloidosis, while stress echocardiography wall-motion analysis extends the platform to stress studies.

Its strongest fit is a service seeking consistent echo quantification across clinical, research or core-lab workflows. DICOM, DICOM-SR, HL7 and PDF outputs support return to PACS and reporting systems, and listed integrations include Fujifilm LISENDO 880, Viz.ai, Studycast and Merge Cardio. An API supports batch analysis for research and core labs. Deployment options include cloud, self-hosted and hybrid models, giving mid-market and enterprise teams flexibility around infrastructure and data flow. These capabilities make Us2.ai more specialized than a general medical-imaging analytics product, but well aligned with cardiac imaging operations.

The published offer includes a 30-day free trial, while the pricing model is contact sales and there is no free plan. Buyers should clarify commercial terms, trial requirements and deployment scope during evaluation. Compliance materials identify SOC 2, ISO 27001, GDPR and HIPAA coverage, and support channels are email and documentation. Cardiology organizations that need automated echo measurements, structured reporting and disease-oriented conclusions should consider Us2.ai. Teams looking for broad modalities, pathology analysis or triage prioritization should choose a platform built for those functions instead.

Us2.ai pros and cons

  • Where it wins
    • Automates chamber, systolic, diastolic and strain measurements
    • Produces guideline-based reports and disease conclusions
    • Supports DICOM, DICOM-SR, HL7, PACS and batch-analysis APIs
  • Where it doesn't
    • Pricing requires contacting sales
    • No free plan is offered
    • Focused on echocardiography rather than broad imaging workflows

Us2.ai fact sheet, pricing and score →

Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.

Last updated · How we research and update